The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Official Title: A Phase 3 Randomized Study Comparing Teclistamab in Combination With Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab SC and Lenalidomide (Tal-DR) Versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Either Ineligible or Not Intended for Autologous Stem Cell Transplant as Initial Therapy
Study ID: NCT05552222
Brief Summary: The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) versus daratumumab, lenalidomide, dexamethasone (DRd).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Royal Prince Alfred Hospital, Camperdown, , Australia
Barwon Health - University Hospital Geelong, Geelong, , Australia
Calvary Mater Newcastle Hospital, New South Wales, , Australia
Wollongong Hospital, Wollongong, , Australia
Princess Alexandra Hospital, Woolloongabba, , Australia
Institut Jules Bordet, Anderlecht, , Belgium
Jolimont, Haine-Saint-Paul, La Louviere, , Belgium
Az Groeninge, Kortrijk, , Belgium
Universitair Ziekenhuis Leuven, Leuven, , Belgium
GZA Ziekenhuizen- Campus St Augustinus, Wilrijk, , Belgium
Fakultni nemocnice Brno, Brno - Bohunice, , Czechia
Fakultni nemocnice Hradec Kralove, Hradec Kralove, , Czechia
Fakultni nemocnice Plzen, Plzen, , Czechia
APHP - Hopital Henri Mondor, Creteil, , France
Hopital Claude Huriez, Lille, , France
CHU Nantes, Nantes, , France
CHU de Bordeaux - Hospital Haut-Leveque, Pessac cedex, , France
CHU Lyon Sud, Pierre-Benite, , France
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, , France
Klinikum Nuernberg Nord, Nuernberg, , Germany
A O U Sant Orsola Malpighi, Bologna, , Italy
Ospedale San Raffaele, Milan, , Italy
IRCCS Policlinico San Matteo, Università degli studi di Pavi, Pavia, , Italy
Istituto Clinico Humanitas, Rozzano, , Italy
Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino, Torino, , Italy
Pusan National University Hospital, Busan, , Korea, Republic of
National Cancer Center, Goyang si, , Korea, Republic of
VUMC Amsterdam, Amsterdam, , Netherlands
Gelre Ziekenhuis, Apeldoorn, , Netherlands
St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, , Netherlands
Pratia Onkologia Katowice, Katowice, , Poland
Swietokrzyskie Centrum Onkologii SPZOZ w Kielcach, Kielce, , Poland
Hosp. Univ. Virgen de Las Nieves, Granada, , Spain
Hosp. Univ. 12 de Octubre, Madrid, , Spain
Hosp. Univ. La Paz, Madrid, , Spain
Hosp. Univ. Hm Sanchinarro, Madrid, , Spain
Hosp. Univ. Son Espases, Palma de Mallorca, , Spain
Hosp. Clinico Univ. de Salamanca, Salamanca, , Spain
Hosp. Mutua Terrassa, Terrassa, , Spain
Hosp. Clinico Univ. de Valencia, Valencia, , Spain
Falu Lasarett, Falun, , Sweden
Skanes universitetssjukhus, Lund, , Sweden
Karolinska University Hospital, Huddinge, Stockholm, , Sweden
Universitetssjukhuset Orebro, Örebro, , Sweden
INSELSPITAL Universitatsspital Bern, Bern, , Switzerland
Kantonsspital St.Gallen, St. Gallen, , Switzerland
Ankara University Medical Faculty, Ankara, , Turkey
Dokuz Eylul University Medical Faculty, Izmir, , Turkey
Ondokuz Mayis University, Samsun, , Turkey
Blackpool Victoria Hospital, Blackpool, , United Kingdom
Kent and Canterbury Hospital, Canterbury, , United Kingdom
Western General Hospital, Edinburgh, , United Kingdom
Imperial College Healthcare, London, , United Kingdom
Name: Janssen Research & Development, LLC Clinical Trial
Affiliation: Janssen Research & Development, LLC
Role: STUDY_DIRECTOR